Cross species application of quantitative neuropathology assays developed for clinical Alzheimer’s disease samples

A major obstacle for preclinical testing of Alzheimer’s disease (AD) therapies is the availability of translationally relevant AD models. Critical for the validation of such models is the application of the same approaches and techniques used for the neuropathological characterization of AD. Deposit...

Descripción completa

Detalles Bibliográficos
Autores principales: Urfer, Silvan R., Latimer, Caitlin S., Ladiges, Warren, Keene, C. Dirk, Benbow, Sarah, Harrison, Benjamin, Promislow, Daniel E.L., Kaeberlein, Matt, Kraemer, Brian C, Wang, Adrienne, Guscetti, Franco, Darvas, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Technical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735310/
https://www.ncbi.nlm.nih.gov/pubmed/31528297
http://dx.doi.org/10.1080/20010001.2019.1657768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735310/
https://www.ncbi.nlm.nih.gov/pubmed/31528297
http://dx.doi.org/10.1080/20010001.2019.1657768

Ejemplares similares